Madryn Asset Management

330 Madison Avenue
New York, NY 10017

Website: madrynlp.com

Firm Size

  • Assets Under Management (AUM):$1.1 Billion
  • Number of Funds:6
  • Employees:12
  • Firm Type:Private Equity
  • Focus Areas:


Description

Madryn Asset Management, LP is a New York-based investment management firm. Founded in 2008, the company primarily focuses on alternative investments, including private equity, venture capital, and real estate. They aim to provide high-quality investment opportunities to their clients and generate attractive risk-adjusted returns. The firm operates with a long-term investment strategy and emphasizes a disciplined approach to asset management. They employ a combination of fundamental analysis, rigorous due diligence, and active management to identify and capitalize on investment opportunities. With a client-centric approach, Madryn Asset Management aims to tailor investment portfolios to meet the unique goals and risk profiles of their clients. In addition, the company places a strong emphasis on risk management and strives to minimize potential downside risks. They actively monitor and adjust their investment strategies to adapt to changing market conditions and ensure the preservation and growth of their clients' capital. Madryn Asset Management has a team of experienced professionals with deep industry knowledge and expertise across various sectors. Their investment professionals conduct thorough research and analysis to uncover investment opportunities and make informed investment decisions. Overall, as a New York-based investment management firm, Madryn Asset Management, LP focuses on alternative investments, employs a disciplined investment approach, and prioritizes risk management to deliver favorable returns for their clients.

Latest News

Powered by

Dec 26, 2023: SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
 SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in response to a press release issued by Madryn Asset Management, LP ("Madryn") on December 26, 2023 , regarding the pending merger with Standard BioTools (Nasdaq: LAB):